When was Big Vision founded?

Big Vision was founded in 2015 and raised its 1st funding round 3 years after it was founded.

Where is Big Vision located?

Big Vision is headquartered in Suzhou, China.

Is Big Vision a funded company?

Big Vision is a funded company, having raised a total of $8.52M across 3 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on Sep 26, 2018.

When was the latest funding round of Big Vision?

Big Vision's latest funding was a $***** Series A round on May 13, 2024, with participation from 1 investor.

Where does Big Vision rank among its competitors?

Big Vision ranks 9th amongst 45 active competitors, of which 8 are funded. It stands 2nd in terms of total funding among its competitors. The most recent competitor to raise funding was Big Vision, which secured $4.15M in May, 2024.

Who are the top competitors of Big Vision?

Big Vision's top competitors include Toku Eyes, Cassini and Diagnostear. Among them, Big Vision secured the most recent funding round in May, 2024.

Big Vision - 2026 Company Profile, Team, Funding & Competitors

Big Vision is a series A company based in Suzhou (China), founded in 2015 by Chen Xinjian. It operates as a Provider of ophthalmology diagnosis and analysis systems. Big Vision has raised $8.52M in funding. The company has 45 active competitors, including 8 funded and 5 that have exited. Its top competitors include companies like Toku Eyes, Cassini and Diagnostear.

Company Details

Provider of ophthalmology diagnosis and analysis systems. The company has developed a multi-platform (Windows, Linux, Mac OS) ophthalmic imaging computer-aided and analysis software MIPA, which integrates disease diagnosis and analysis, disease growth prediction, efficacy evaluation, and others. The software is based on ophthalmic-image processing algorithms.

Website: www.bigvisiontech.com
Email ID: *****@bigvisiontech.com
Phone Number: +86 **********

Key Metrics

Founded Year

2015

Location

Suzhou, China

Stage

Series A

Total Funding

$8.52M in 3 rounds

Latest Funding Round

Series A, May 13, 2024, $*****

Investors

SND Ventures Group & 2 more

Ranked

9^th among 45 active competitors

Similar Companies

Abridge Inc & 2376 more

View Big Vision's full profile

Big Vision has raised a total funding of $8.52M over 3 rounds. Its first funding round was on Sep 26, 2018. Its latest funding round was a Series A round on May 13, 2024 for $*****. 1 investor participated in its latest round. Big Vision has 3 institutional investors.

Here is the list of recent funding rounds of Big Vision:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
May 13, 2024	4508781	Series A	4758627	9256693	2825906	4254546
Dec 16, 2021	8929198	Series A	4904219	3736600	6015086	SND Ventures Group & 1 more
Sep 26, 2018	1107637	Series A	8613504	7575091	1899448	7443029

Access funding benchmarks and valuations. Sign up today!

View details of Big Vision's funding rounds and investors

The founders of Big Vision is Chen Xinjian.

Here are the details of Big Vision's key team members:

Chen Xinjian: Founder of Big Vision.

View details of Big Vision's Founder profiles and Board Members

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Big Vision include Toku Eyes, Cassini and Diagnostear. Here is the list of Top 10 competitors of Big Vision, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Toku Eyes 2018, Auckland (New Zealand), Acquired	Developer of AI-powered retinal image analysis for early disease detection. This company offers tools that analyze retinal images to identify indicators of various health conditions, including cardiovascular risk and chronic kidney disease. The technology utilizes artificial intelligence to provide non-invasive, real-time assessments, potentially enabling earlier diagnosis and intervention. The company's products are subject to varying regulatory approvals depending on the region.	$10.5M	National Vision, Topconhealthcare & 16 others	57/100
2nd	Cassini 2006, The Hague (Netherlands), Series A	Provider of corneal diagnostic solutions	$547K	IPF Partners, Innovation Industries	53/100
3rd	Diagnostear 2013, Tel Aviv (Israel), Public	Point-of-care diagnostic assay for Dry Eye Syndrome	$2.85M	Elcam Medical	43/100
4th	Pr3vent 2017, San Francisco (United States), Series A	Provider of AI-based platform for ophthalmic conditions in newborns	$2.5M	Trousdale Ventures, InFocus Capital Partners ... & 1 others	42/100
5th	Octlight 2014, Lyngby (Denmark), Seed	Provider of non-invasive medical imaging light sources for eye diagnosis	$1.44M	Syddansk Innovation, Ministry of Education and Research ... & 4 others	41/100
6th	TearLab 2003, San Diego (United States), Acquired	Developer of diagnostic tests for detecting hyperosmolarity	-	CRG, Greybrook	40/100
7th	Shanggong Medical Letter 2014, Beijing (China), Series A	Provider of fundus screening and chronic disease management	$7.32M	DM Capital, Korea Investment Partners & 3 others	37/100
8th	BioLight 2005, Tel Aviv (Israel), Public	Diagnostics and therapeutics for ophthalmology	-	-	36/100
9th	Big Vision 2015, Suzhou (China), Series A	Provider of ophthalmology diagnosis and analysis systems	$8.52M	SND Ventures Group, Kunshan High-tech Venture Capital ... & 1 others	36/100
10th	CSO 1967, Florence (Italy), Funding Raised	Provides ophthalmic instruments	-	EIC Fund, Europa	34/100